Edition:
United States

Xvivo Perfusion AB (XVIVO.ST)

XVIVO.ST on Stockholm Stock Exchange

144.60SEK
12:00pm EDT
Change (% chg)

1.80kr (+1.26%)
Prev Close
142.80kr
Open
141.00kr
Day's High
147.00kr
Day's Low
140.60kr
Volume
19,044
Avg. Vol
39,891
52-wk High
169.00kr
52-wk Low
82.00kr

Chart for

About

Xvivo Perfusion AB is a Sweden-based medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. The Company operates in two segments: Durable goods and Non-Durable goods. The Durable goods segment comprises sale and rental income from XVIVO... (more)

Overall

Beta: 0.76
Market Cap(Mil.): kr3,808.10
Shares Outstanding(Mil.): 26.19
Dividend: --
Yield (%): --

Financials

  XVIVO.ST Industry Sector
P/E (TTM): 296.50 38.68 32.14
EPS (TTM): 0.49 -- --
ROI: 2.48 13.89 12.83
ROE: 2.49 16.74 14.95

BRIEF-XVIVO Perfusion Has Submitted Premarket Approval Application For XPS With STEEN Solution To FDA

* XVIVO PERFUSION HAS SUBMITTED PREMARKET APPROVAL APPLICATION FOR XPS WITH STEEN SOLUTION TO FDA Source text for Eikon: Further company coverage:

May 11 2018

BRIEF-Xvivo Perfusion Q1 Adjusted. EBITDA Sek 7.2 Million

* Q1 ADJUSTED. EBITDA SEK 7.2 MILLION VERSUS SEK 5.0 MILLION YEAR AGO

Apr 26 2018

Earnings vs. Estimates